Accelera Innovations, Inc (ACNV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 18, 2025
Accelera Innovations Market Cap
Accelera Innovations has a market cap or net worth of $8.14 thousand as of August 29, 2025. Its market cap has decreased by -96.30% in one year.
Market Cap
8.14K
Enterprise Value
n/a
Revenue
1.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 27, 2015, Accelera Innovations's market cap has decreased from 87.21M to 8.14K, a decrease of -99.99%. That is a compound annual growth rate of -58.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 8.14K | 9,950.62% |
| Dec 6, 2023 | 81.00 | -99.01% |
| Dec 29, 2022 | 8.14K | -96.55% |
| Dec 30, 2020 | 236.08K | -27.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 837.26M |
| Elite Pharmaceuticals | 705.48M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 661.90M |
| Northwest Biotherapeutics | 443.96M |
| CytoDyn | 393.58M |
| American Oncology Network | 358.34M |